Purpose of review: To understand the impact of attention deficit hyperactivity disorder (ADHD) and its medications on blood pressure (BP) in children and adolescents and provide recommendations for management of elevated BP in children and adolescents with ADHD.
Recent findings: ADHD medications have cardiovascular effects including elevated BP. However, the bulk of the evidence indicates that stimulants and other ADHD medications are safe and do not cause severe cardiovascular diseases. BP should be assessed carefully at the time of ADHD diagnosis, because some behavioral changes similar to ADHD may be associated with hypertension. ADHD medications appear to be safe. However, their long-term impact on the cardiovascular system is not clearly understood and needs further investigation. BP should be monitored regularly during ADHD pharmacotherapy in order to optimize the management of both conditions.
Keywords: ADHD; Cardiovascular disease; Elevated blood pressure; Pediatric hypertension; Stimulants.
Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9. CNS Drugs. 2013. PMID: 23160939 Review.
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.CNS Drugs. 2017 Mar;31(3):199-215. doi: 10.1007/s40263-017-0410-7. CNS Drugs. 2017. PMID: 28236285 Free PMC article. Review.
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev. 2014 Sep 19;(9):CD006997. doi: 10.1002/14651858.CD006997.pub2. Cochrane Database Syst Rev. 2014. PMID: 25238582 Review.
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.J Child Adolesc Psychopharmacol. 2013 Sep;23(7):432-9. doi: 10.1089/cap.2012.0111. Epub 2013 Sep 9. J Child Adolesc Psychopharmacol. 2013. PMID: 24015896 Free PMC article.
Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.CNS Drugs. 2013 Jul;27(7):531-43. doi: 10.1007/s40263-013-0084-8. CNS Drugs. 2013. PMID: 23757186 Review.